Clinical Trials Directory

Trials / Unknown

UnknownNCT05010889

Quality of Life After POEM for Achalasia

Health-Related Quality of Life After Peroral Endoscopic Myotomy for Patients With Achalasia

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
First Affiliated Hospital, Sun Yat-Sen University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Achalasia is an esophageal motility disorder, characterized by insufficient lower esophageal sphincter relaxation and loss of esophageal peristalsis. Patients with achalasia experience distressing gastrointestinal symptoms, including dysphagia, reflux and chest pain, which lead to weight loss and malnutrition. Undoubtedly, health-related quality of life can be significantly diminished in patients with achalasia. At present, POEM has become one of the standard therapies for achalasia. Limited studies have focused on the patient's quality of life before and after POEM. The present study aimed to assess the changes in quality of life of patients with achalasia using the validated achalasia severity questionnaire (ASQ) and the short form (SF)-36 scale.

Conditions

Interventions

TypeNameDescription
PROCEDUREPeroral endoscopic myotomy (POEM)POEM is performed as previously described by Inoue et al (Endoscopy 2010), including four main steps mucosal incision, submucosal tunneling, myotomy and mucosal entry closure.

Timeline

Start date
2021-09-01
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2021-08-18
Last updated
2021-08-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05010889. Inclusion in this directory is not an endorsement.